Summary
The most common cerebral complications of bacterial (purulent) meningitis are generalized brain edema, cerebrovascular arterial or venous complications and hydrocephalus. These complications may cause an increase in intracranial pressure. In severe, complicated clinical courses of bacterial meningitis adjunctive therapeutic strategies, e. g., intravenous intravenous administration of hyperosmolar agents (mannitol) and external intraventricular drainage, are used in addition to antibiotics. If septic sinus or cortical venous thrombosis is diagnosed using MRI, dose-adjusted intravenous heparin has to be considered. Recent data from a prospective randomized multicenter trial in adults with bacterial meningitis showed a beneficial effect of intravenous dexamethasone when compared with placebo in patients with pneumococcal meningitis. According to these results, dexamethasone is recommended in adults with suspected bacterial meningitis (i. e., clinical suspicion plus cloudy cerebrospinal fluid (CSF), detection of bacteria in the CSF by means of Gram’s stain, or a CSF pleocytosis of >1000 cells/μl).
Zusammenfassung
Zu den wichtigsten zerebralen Komplikationen der bakteriellen (eitrigen) Meningitis gehören: generalisiertes Hirnödem, zerebrovaskuläre arterielle oder venöse Komplikationen und Hydrozephalus. Diese Komplikationen können zu einem Anstieg des intrakraniellen Drucks führen. Bei schweren, komplizierten klinischen Verläufen der bakteriellen Meningitis werden zusätzlich zu den Antibiotika verschiedene adjuvante Therapiemaßnahmen eingesetzt, z. B. intravenöse Gabe von hyperosmolaren Substanzen (Mannit) und externe intraventrikuläre Liquordrainage. Wenn im Kernspintomogramm eine septische Sinusoder kortikale Venenthrombose nachweisbar ist, sollte die Dosisadaptierte intravenöse Heparintherapie erwogen werden. Die kürzlich publizierten Daten einer prospektiven, randomisierten, multizentrischen Doppelblindstudie bei Erwachsenen mit bakterieller Meningitis zeigten einen günstigen Effekt einer intravenösen Dexamethasontherapie im Vergleich zu Placebo bei Patienten mit Pneumokokkenmeningitis. Aufgrund dieser Studie wird die Gabe von Dexamethason bei erwachsenen Patienten mit V. a. bakterielle Meningitis (d. h. klinischer Verdacht plus trüber Liquor, Nachweis von Bakterien im Liquor in der Gramfärbung oder einer Liquorpleozytose von >1000/μl) empfohlen.
Similar content being viewed by others
References
Andersen J, Backer V, Voldsgrard P et al (1997) Acute meningococcal meningitis. Analysis of features of the disease according to the age of 255 patients. J Infect 34:227–235
Centers for Disease Control (2002) Progress toward elimination of Haemophilus influenzae type b invasive disease among infants and children-United States, 1998–2000. MMWR 51:234–237
De Gans J, van de Beek D for the European Dexamethasone in Adulthood Bacterial Meningitis Study Investigators (2002) Dexamethasone in adults with bacterial meningitis. N Engl J Med 347:1549–1556
Durand ML, Calderwood SB, Weber DJ, Miller SI, Southwick FS, Caviness VS Jr, Swartz MN (1993) Acute bacterial meningitis. A review of 493 episodes. N Engl J Med 328:21–28
Haring HP, Rötzer HK, Reindl H, Berek K, Kampfl A, Pfausler B, Schmutzhard E (1993) Time course of cerebral blood flow velocity in central nervous system infections. Arch Neurol 50:98–101
Heyderman RS, Lambert HP, O’Sullivan I et al (2003) Early management of suspected bacterial meningitis and meningococcal septicaemia in adults. J Infect 46:75–77
Jan W, Zimmerman RA, Bilaniuk LT et al (2003) Diffusion-weighted imaging in acute bacterial meningitis in infancy. Neuroradiology 45:634–639
Kastenbauer S, Pfister HW (2003) Pneumococcal meningitis in adults: spectrum of complications and prognostic factors in a series of 87 cases. Brain 126:1015–1025
Koedel U, Scheld WM, Pfister HW (2002) Pathogenesis and pathophysiology of pneumococcal meningitis. Lancet Infect Dis 2:721–736
McCormick AW, Whitney CG, Farley MM et al (2003) Geographic diversity and temporal trends of antimicrobial resistance in Streptococcus pneumoniae in the United States. Nat Med 9:424–430
McIntyre PB, Berkey CS, King S et al (1997) Dexamethasone as adjunctive therapy in bacterial meningitis. JAMA 278:925–931
MiQ (Qualitätsstandards in der mikrobiologisch-infektiologischen Diagnostik) (2001) Infektionen des Zentralnervensystems. Kniehl E, Dörries R, Geiß HK, Matz B, Neumann-Häfelin D, Pfister HW, Prange H, Schlüter D, Spellerberg B, Spencker FB. Urban & Fischer
Müller M, Merkelbach S, Hermes M, König J, Schimrigk K (1998) Relationship between short-term outcome and occurence of cerebral artery stenosis in survivors of bacterial meningitis. J Neurol 245:87–92
Mylonakis E, Hohmann EL, Calderwoud SB (1998) Central nervous system infection with Listeria monocytogenes. 33 years’ experience at a general hospital and review of 776 episodes from the literature. Medicine 77:313–336
Nau R, Brück W (2002) Neuronal injury in bacterial meningitis: mechanisms and implications for therapy. Trends Neurosci 25:38–45
Oliver WJ, Shope TC, Kuhns LR (2003) Fatal lumbar puncture: fact versus fiction- an approach to a clinical dilemma. Pediatrics 112:174–176
Pfausler B, Spiss H, Beer R et al (2003) Treatment of staphylococcal ventriculitis associated with external cerebrospinal fluid drains: a prospective randomized trial of intravenous compared with intraventricular vancomycin therapy. J Neurosurg 98:1040–1044
Pfister HW, Feiden W, Einhäupl KM (1993) The spectrum of complications during bacterial meningitis in adults: results of a prospective clinical study. Arch Neurol 50:575–580
Pfister HW (2002) Meningitis. Kohlhammer, Stuttgart. In: Diener HC (Hrsg) Leitlinien für Diagnostik und Therapie in der Neurologie. Thieme, Stuttgart
Pfister HW, Müller M, Nau R (2003) Bakterielle Meningoenzephalitis
Pfister HW, Roos KL (2003) Bacterial meningitis: In: Noseworthy JH (ed) Neurological Therapeutics. Principles and Practice, Vol. 1. Dunitz, London New York, p 863–873
Pfister HW, Roos K (2004) Bacterial meningitis. In: Strauss M (Ed) Principles of Neurological Infectious Diseases. McGraw-Hill New York (in press)
Pomeroy SL, Holmes SJ, Dodge PR, Feigin RD (1990) Seizures and other neurologic sequelae of bacterial meningitis in children. New Engl J Med 323:1651–1657
Robert-Koch-Institut (2003) Invasive Meningokokken-Erkrankungen im Jahr 2002. Epidemiologisches Bulletin 50:415–418
Schuchardt V (1991) Akutverlauf und Langzeitprognose intensivmedizinisch behandelter Entzündungen des Nervensystems. Thieme Copythek, Stuttgart
Southwick FS (1995) Septic thrombophlebitis of major dural venous sinuses. Curr Clin Trop Infect Dis 15:179–203
Van de Beek D, de Gans J, McIntyre P et al (2003) Corticosteroids in acute bacterial meningitis. Cochrane Database Syst Rev CD004305
Viale P, Pagani L, Cristini F et al (2002) Linezolid for the treatment of central nervous system infections in neurosurgical patients. Scand J Infect Dis 34:456–459
Winkler F, Kastenbauer S, Yousry TA et al (2002) Discrepancy between cranial CT scan and clinically relevant raised intracranial pressure (ICP) in adults with pneumococcal meningitis: should ICP monitoring be performed early? J Neurol 249:1292–1297
Author information
Authors and Affiliations
Corresponding author
Additional information
Serie: Die Intensivtherapie bei Entzündungen des Nervensystems Herausgegeben von U. Meyding-Lamadé, V. Schuchardt und E. Schmutzhard
Rights and permissions
About this article
Cite this article
Rupprecht, T.A., Pfister, HW. Aktuelle klinische Aspekte der bakteriellen Meningitis. Intensivmed 41, 565–572 (2004). https://doi.org/10.1007/s00390-004-0549-6
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s00390-004-0549-6